Aquestive Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $13,542 | $20,099 | $12,053 | $13,206 |
Gross Profit | 9,105 | 15,573 | 7,664 | 8,527 |
EBITDA | -7,152 | 260 | -8,421 | -4,308 |
EBIT | -7,311 | 55 | -8,628 | -4,775 |
Net Income | -11,509 | -2,745 | -12,828 | -8,111 |
Net Change In Cash | 13,542 | 20,099 | 12,053 | 13,206 |
Free Cash Flow | -11,960 | -7,041 | -10,413 | -4,958 |
Cash | 77,893 | 89,870 | 95,200 | 23,872 |
Basic Shares | 91,082 | 90,911 | 73,614 | 68,533 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $50,583 | $47,680 | $50,832 | $45,849 |
Gross Profit | 29,752 | 28,294 | 35,843 | 32,885 |
EBITDA | 1,182 | -39,580 | -45,114 | -39,153 |
EBIT | -163 | -41,967 | -48,078 | -42,761 |
Net Income | -7,870 | -60,202 | -90,036 | -65,362 |
Net Change In Cash | 50,583 | 47,680 | 50,832 | 45,849 |
Cost of Revenue | -3,783 | -17,519 | ||
Free Cash Flow | -7,375 | -12,313 | -33,892 | -45,976 |
Cash | 23,872 | 27,273 | 28,024 | 31,807 |
Basic Shares | 61,255 | 48,734 | 38,077 | 33,651 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.13 |
2024-06-30 | -$0.03 |
2024-03-31 | -$0.17 |
2023-12-31 | -$0.11 |
